482 related articles for article (PubMed ID: 29110767)
1. Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies.
Illes Z; Blaabjerg M
Handb Clin Neurol; 2017; 146():125-138. PubMed ID: 29110767
[TBL] [Abstract][Full Text] [Related]
2. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
[TBL] [Abstract][Full Text] [Related]
3. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
[TBL] [Abstract][Full Text] [Related]
4. IL-8 as a potential biomarker in Guillain-Barre Syndrome.
Breville G; Lascano AM; Roux-Lombard P; Lalive PH
Eur Cytokine Netw; 2019 Dec; 30(4):130-134. PubMed ID: 32096474
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
Kmezic I; Samuelsson K; Finn A; Upate Z; Blennow K; Zetterberg H; Press R
Eur J Neurol; 2022 Sep; 29(9):2810-2822. PubMed ID: 35638376
[TBL] [Abstract][Full Text] [Related]
6. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome.
Arcila-Londono X; Lewis RA
Semin Neurol; 2012 Jul; 32(3):179-86. PubMed ID: 23117942
[TBL] [Abstract][Full Text] [Related]
8. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
9. CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
Capodivento G; De Michelis C; Carpo M; Fancellu R; Schirinzi E; Severi D; Visigalli D; Franciotta D; Manganelli F; Siciliano G; Beronio A; Capello E; Lanteri P; Nobile-Orazio E; Schenone A; Benedetti L; Nobbio L
J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):303-310. PubMed ID: 33093191
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
11. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.
Breville G; Lascano AM; Roux-Lombard P; Vuilleumier N; Lalive PH
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34140310
[TBL] [Abstract][Full Text] [Related]
13. Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies.
Heming M; Schulte-Mecklenbeck A; Brix T; Wolbert J; Ruland T; Klotz L; Meuth SG; Gross CC; Wiendl H; Meyer Zu Hörste G
Front Immunol; 2019; 10():515. PubMed ID: 30984164
[No Abstract] [Full Text] [Related]
14. Inflammatory neuropathies.
Whitesell J
Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
[TBL] [Abstract][Full Text] [Related]
15. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
16. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.
Nishino S; Kanbayashi T; Fujiki N; Uchino M; Ripley B; Watanabe M; Lammers GJ; Ishiguro H; Shoji S; Nishida Y; Overeem S; Toyoshima I; Yoshida Y; Shimizu T; Taheri S; Mignot E
Neurology; 2003 Sep; 61(6):823-5. PubMed ID: 14504329
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
18. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
Umapathi T; Li Z; Verma K; Yuki N
Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology.
Bourque PR; Brooks J; Warman-Chardon J; Breiner A
J Neurol; 2020 Mar; 267(3):746-751. PubMed ID: 31734909
[TBL] [Abstract][Full Text] [Related]
20. [Immune-mediated neuropathies].
Stoll G; Reiners K
Nervenarzt; 2016 Aug; 87(8):887-98. PubMed ID: 27474733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]